Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and... Abstract Current guidelines recommend completion axillary lymphnode dissection (ALND) when sentinel lymphnode (SLN) contains metastatic tumor deposit. In consequent ALND sentinel node is the only node involved by tumor in 40–70 % of cases. Recent studies demonstrate the oncologic safety of omitting completion ALND in low risk patients. Several nomograms (MSKCC, Stanford, MD Anderson score, Tenon score) had been developed in predicting the likelihood of additional nodes metastatic involvement. We evaluated accuracy of MSKCC nomogram and other clinicopathologic variables associated with additional lymph node metastasis in our patients. A total of 334 patients with primary breast cancer patients underwent SLN biopsy during the period Jan 2007 to June 2014. Clinicopathologic variables were prospectively collected. Completion ALND was done in 64 patients who had tumor deposit in SLN. The discriminatory accuracy of nomogram was analyzed using Area under Receiver operating characteristic curve (ROC). SLN was the only node involved with tumor in 69 % (44/64) of our patients. Additional lymph node metastasis was seen in 31 % (20/64). On univariate analysis, extracapsular infiltration in sentinel node and multiple sentinel nodes positivity were significantly associated (p < 0.05) with additional lymph node metastasis in the axilla. Area under ROC curve for nomogram was 0.58 suggesting poor performance of the nomogram in predicting NSLN involvement. Sentinel nodes are the only nodes to be involved by tumor in 70 % of the patients. Our findings indicate that multiple sentinel node positivity and extra-capsular invasion in sentinel node significantly predicted the likelihood of additional nodal metastasis. MSKCC nomogram did not reliably predict the involvement of additional nodal metastasis in our study population. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Indian Journal of Surgical Oncology Springer Journals

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/factors-influencing-non-sentinel-node-involvement-in-sentinel-node-Imwf4tNVVV
Publisher
Springer Journals
Copyright
2015 Indian Association of Surgical Oncology
ISSN
0975-7651
eISSN
0976-6952
DOI
10.1007/s13193-015-0431-y
Publisher site
See Article on Publisher Site

Abstract

Abstract Current guidelines recommend completion axillary lymphnode dissection (ALND) when sentinel lymphnode (SLN) contains metastatic tumor deposit. In consequent ALND sentinel node is the only node involved by tumor in 40–70 % of cases. Recent studies demonstrate the oncologic safety of omitting completion ALND in low risk patients. Several nomograms (MSKCC, Stanford, MD Anderson score, Tenon score) had been developed in predicting the likelihood of additional nodes metastatic involvement. We evaluated accuracy of MSKCC nomogram and other clinicopathologic variables associated with additional lymph node metastasis in our patients. A total of 334 patients with primary breast cancer patients underwent SLN biopsy during the period Jan 2007 to June 2014. Clinicopathologic variables were prospectively collected. Completion ALND was done in 64 patients who had tumor deposit in SLN. The discriminatory accuracy of nomogram was analyzed using Area under Receiver operating characteristic curve (ROC). SLN was the only node involved with tumor in 69 % (44/64) of our patients. Additional lymph node metastasis was seen in 31 % (20/64). On univariate analysis, extracapsular infiltration in sentinel node and multiple sentinel nodes positivity were significantly associated (p < 0.05) with additional lymph node metastasis in the axilla. Area under ROC curve for nomogram was 0.58 suggesting poor performance of the nomogram in predicting NSLN involvement. Sentinel nodes are the only nodes to be involved by tumor in 70 % of the patients. Our findings indicate that multiple sentinel node positivity and extra-capsular invasion in sentinel node significantly predicted the likelihood of additional nodal metastasis. MSKCC nomogram did not reliably predict the involvement of additional nodal metastasis in our study population.

Journal

Indian Journal of Surgical Oncology – Springer Journals

Published: Dec 1, 2015

Keywords: surgical oncology; oncology; surgery

References

  • Incidence of breast carcinoma-related lymphedema
    JA Petrek, MC Heelan
  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
    U Veronesi, G Paganelli, V Galimberti
  • Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy
    S Scomersi, L Torelli, F Zanconati
  • A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    K. J. Zee, D. M. Manasseh, J. L. Bevilacqua
  • A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive
    A Pal, E Provenzano, SW Duffy, SE Pinder, AD Purushotham
  • New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
    HE Kohrt, RA Olshen, HR Bermas
  • An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement
    E Barranger, C Coutant, A Flahault
  • Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer
    RF Hwang, S Krishnamurthy, KK Hunt
  • Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity
    N Soni, H Carmalt, D Gillett
  • Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy
    L Lambert, G Ayers, R Hwang, K Hunt, M Ross, H Kuerer
  • The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram
    M Cripe, L Beran, W Liang, B Sickle-Santanello
  • Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy
    S Alran, Y Rycke, V Fourchotte
  • Comparison of two models for the prediction of nonsentinel node metastases in breast cancer
    R Ponzone, F Maggiorotto, L Mariani
  • Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population
    RF Parra, CM Francissen, PG Peer, MF Ernst
  • The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population
    M Klar, A Jochmann, M Foeldi
  • Validation of nomograms to predict the risk of non-sentinel lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement
    S Hidara, I Harrabia, L Benregaya
  • Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006
    L. Tryggvadóttir, M. Gislum, F. Bray
  • EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
    M. Sant, C. Allemani, M. Santaquilani
  • Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 Randomized Trial
    A Giuliano, L Linda McCall, P Beitsch
  • Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)–ACOSOG Z0011 Results and beyond
    W Gatzemeier, GB Mann
  • Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer
    M Noguchi
  • Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
    I Langer, U Guller, CT Viehl
  • Performance of sentinel node dissection as definitive treatment for node negative breast cancer patients
    R Ponzone, N Biglia, F Maggiorotto
  • Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?
    AE Giuliano, M Morrow, S Duggal, TB Julian
  • Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations
    DD D’Angelo-Donovan, D Dickson-Witmer, NJ Petrelli
  • Predicting the status of the nonsentinel axillary nodes
    SL Wong, MJ Edwards, C Chao
  • Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis
    KA Joseph, M El-Tamer, I Komenaka, A Troxel
  • Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer
    RF Hwang, S Krishnamurthy, KK Hunt
  • Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases
    D.E. Boler, C. Uras, U Ince
  • Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node
    RR Turner, Ku Chu, K Qi, NM Hansen, EC Glass, AE Giuliano
  • New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
    HE Kohrt, RA Olshen, HR Bermas, WH Goodson, DJ Wood
  • (2001) Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    MR Weiser, LL Montgomery, LK Tan
  • Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: a metaanalysis
    AC Degnim, KA Griffith, MS Sabel
  • Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?
    C Reynolds, R Mick, JH Donohue
  • Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
    KU Chu, RR Turner, NM Hansen
  • Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
    DN Krag, SJ Anderson, TB Julian
  • Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial
    KK Hunt, KV Ballman, LM McCall, JC Boughey, EA Mittendorf
  • Prognostic features in patients with stage T1 breast carcinoma and a 0.5 cm or less lymph node metastasis
    NS Goldstein, A Mani, F Vicini, J Ingold
  • Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node pilot study
    H Eldweny, K Alkhaldy, N Alsaleh
  • International multicenter tool to predict the risk of nonsentinel node metastasis in breast cancer
    TJ Meretoja, MHK Leidenius, PS Heikkilä
  • Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden
    KB Stitzenberg, AA Meyer, SL Stern
  • Clinicopathological Factors Predicting Non-Sentinel Lymph Node Metastasis of Breast Cancer in Iran
    SA Moosavi, A Abdirad, R Omranipour
  • Factors predicting the sentinel and nonsentinel lymph node metastases in breast cancer
    V Ozmen, H Karanlik, N Cabioglu
  • Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study
    C Coutant, C Olivier, E Lambaudie, E Fondrinier, F Marchal, F Guillemin
  • Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands?
    M.L. Smidt, D.M. Kuster, G.J. Wilt
  • Non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node: validation of five nomograms and development of a new predictive model
    A Lombardi, S Maggi, M Lo Russo, F Scopinaro, D Stefano, MG Pittau
  • Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity
    NK Soni, HL Carmalt, DJ Gillett, AJ Spillane
  • Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison
    YL Kuo, WC Chen, WJ Yao
  • Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement
    S Hidar, I Harrabi, L Benregaya, R Fatnassi, A Khelifi, A Benabdelkader
  • Memorial SloaneKettering Cancer Center nomogram to predict the risk of non-sentinel lymph node metastasis in japanese breast cancer patients
    T Sasada, S Murakami, T Kataoka, M Ohara, S Ozaki, M Okada
  • Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non-sentinel lymph node
    C Amanti, A Lombardi, S Maggi, A Moscaroli, M Lo Russo, R Maglio
  • Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram
    RF Parra, MF Ernst, JL Bevilacqua, SJ Mol, KJ Zee, JM Broekman
  • Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study
    AS Gur, B Unal, U Ozbek, V Ozmen, F Aydogan, S Gokgoz
  • Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the Canadian experience
    E Poirier, L Sideris, P Dube, P Drolet, SH Meterissian
  • Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer
    A Pinero, M Canteras, A Moreno, F Vicente, J Gimenez, A Tocino
  • Predicting nonsentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population?
    O Coufal, T Pavlik, P Fabian, R Bori, G Boross, I Sejben
  • Value of Memorial Sloan Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer
    I Hoven, GP Kuijt, AC Voogd
  • Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems
    A Sanjuan, G Escaramis, S Vidal-Sicart, M Illa, G Zanon, J Pahisa
  • Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer
    Y Moghaddam, M Falzon, L Fulford, NR Williams, MR Keshtgar
  • Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients
    JL Fougo, FS Senra, C Araujo, T Dias, M Afonso, C Leal
  • 33–106
    Forza Operativa sul Carcinoma Mammario. Linee guida sulla diagnosi,il trattamento e la riabilitazione. Aggiornamento
  • Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?
    A Woznick, M Franco, P Bendick, PR Benitez
  • Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node–positive breast cancer patients. Letters to the Editor
    G. Cserni
  • Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients
    L. Kocsis, M. Svebis, G. Boross
  • Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity
    N.K. Soni, H.L. Carmalt, D.J. Gillett, A.J Spillane
  • Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram
    A.C Degnim, C. Reynolds, G. Pantvaidya
  • Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy
    AS Gur, B Unal, R Johnson, G Ahrendt, M Bonaventura, P Gordon
  • Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms
    G D’Eredità, VL Troilo, C Giardina
  • Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-Echelon nodes in the axilla
    VJ Kamath, R Giuliano, EL Dauway
  • Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer
    FD Rahusen, H Torrenga, PJ Diest
  • Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
    M Donker, G Tienhoven, ME Straver